About
Philippe has been a Partner at Auriga Partners since 1999. Philippe has been an early stage investor in numerous successful healthcare companies including Alantos Pharmaceuticals (acquired by Amgen), Innate Pharma (EuroNext Paris: IPH), Spine Next (acquired by Abbott), Targacept (Nasdaq: TRGT), Tigenix (EuroNext : TIG). He currently serves on the board of directors of several portfolio companies including, Novagali Pharma (France) and Genocea Biosciences (Etats-Unis). Prior to joining Auriga Partners, Philippe was an equity analyst with HSBC-CCF Securities, covering biotech and biopharma public stocks. He holds a MS in Molecular Biology from the University of Paris VII and a MS in finance from ESSEC (Paris).
Position in the VCSift Database
- • 11 investors at Kurma Partners are tracked.
- • 658 investors hold the Partner role in VCSift. Philippe Peltier is one of them.
- • 2,833 investors are based in Paris, Ile-de-France, France.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Paris, France
Contact Information
Find more investors like Philippe
Search Investors